Clinical Development Director | Principal Clinical Research Scientist | Principal Scientist @ (January 2005 - January 2015)
Clinical Development Director | Principal Clinical Research Scientist | Principal Scientist @ (October 2005 - April 2015)
Postdoctoral Research Fellow, Neuroscience Discovery Research @ Eli Lilly and Company (January 2002 - January 2005)
Matthew Barton Education
University of Utah
PhD (Pharmacology and Toxicology)
2002
University of Iowa
BS
1996-1996
Matthew Barton Skills
Drug Development
Pharmacology
Clinical Research
Clinical Development
Clinical Trials
Clinical Pharmacology
Drug Discovery
In Vivo
Biomarkers
Neuroscience
Infectious Diseases
Animal Models
Translational Medicine
In Vitro
Lifesciences
Molecular Biology
Pharmaceutical Industry
GCP
Biotechnology
Protocol
CRO
Oncology
Assay Development
GLP
Life Sciences
Neuroinflammation
Early Clinical Development
Epilepsy
Muscle Metabolism
Multiple Sclerosis
Stroke
Anti infectives
Gastrointestinal Disorders
Gastroparesis
CRO Management
Good Clinical Practice (GCP)
CTAs
Leadership
Applications
Matlab
Good Clinical Practice Gcp
Cell Culture
Strategic Planning
Operations
Research Ethics
Microsoft Excel
Research
Science
Integration
Good Clinical Practice
Matthew Barton Summary
Matthew Barton, based in Raleigh, NC, US, is currently a Development Lead | Head of Regulatory Stakeholders | Alzheimer’s Disease at UCB. Matthew Barton brings experience from previous roles at UCB, Prothena Corporation and Gan & Lee Pharmaceuticals. Matthew Barton holds a PhD in Pharmacology and Toxicology @ University of Utah. With a robust skill set that includes Drug Development, Pharmacology, Clinical Research, Clinical Development, Clinical Trials and more. Matthew Barton has 6 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Matthew Barton?
Find contact details for 700 million professionals.